KIA
SUPN icon

Kopp Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Kopp Investment Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.36M Sell
49,462
-27,930
-36% -$828K 2.5% 13
2019
Q2 		$2.56M Sell
77,392
-22,583
-23% -$774K 2.92% 15
2019
Q1 		$3.5M Buy
99,975
+24,013
+32% +$893K 2.83% 17
2018
Q4 		$2.52M Buy
75,962
+34,262
+82% +$1.47M 2.46% 19
2018
Q3 		$2.1M Sell
41,700
-179
-0.4% -$8.84K 1.77% 22
2018
Q2 		$2.51M Buy
41,879
+4,903
+13% +$254K 2.35% 21
2018
Q1 		$1.69M Sell
36,976
-7,145
-16% -$298K 1.72% 24
2017
Q4 		$1.76M Sell
44,121
-1,710
-4% -$67.6K 1.76% 20
2017
Q3 		$1.83M Buy
45,831
+49
+0.1% +$2.12K 1.68% 22
2017
Q2 		$1.97M Sell
45,782
-773
-2% -$27.5K 1.77% 24
2017
Q1 		$1.46M Buy
46,555
+566
+1% +$15.2K 1.42% 24
2016
Q4 		$1.16M Sell
45,989
-850
-2% -$19K 1.23% 28
2016
Q3 		$1.16M Sell
46,839
-1,045
-2% -$23.7K 1.14% 27
2016
Q2 		$975K Buy
+47,884
New +$849K 0.52% 33
2015
Q4 		– Sell
-729,960
Closed -$10.2M – 68
2015
Q3 		$10.2M Sell
729,960
-160,745
-18% -$2.99M 5.51% 5
2015
Q2 		$15.1M Buy
890,705
+277,115
+45% +$3.94M 6.74% 4
2015
Q1 		$7.42M Buy
613,590
+8,345
+1% +$78.9K 3.28% 8
2014
Q4 		$5.02M Sell
605,245
-115,820
-16% -$973K 2.42% 12
2014
Q3 		$6.27M Buy
721,065
+56,595
+9% +$511K 3.1% 11
2014
Q2 		$7.28M Buy
664,470
+498,640
+301% +$4.44M 3.34% 10
2014
Q1 		$1.48M Buy
+165,830
New +$1.53M 0.62% 32

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Kopp Investment Advisors's SUPN Position: Q3 2019 in Review

Kopp Investment Advisors reduced its Supernus Pharmaceuticals (SUPN) stake by 36% in Q3 2019, selling an estimated $828K and leaving 49,462 shares worth $1.36M. The position accounts for 2.5% of the portfolio, ranked #13.

Kopp Investment Advisors first reported a position in SUPN in Q1 2014 and has held it in 21 quarters since. The position peaked at $15.1M in Q2 2015. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.

  • Kopp Investment Advisors held 49,462 shares of Supernus Pharmaceuticals worth $1.36M as of Q3 2019.
  • Kopp Investment Advisors sold 27,930 Supernus Pharmaceuticals shares in Q3 2019, an estimated $828K.
  • Supernus Pharmaceuticals made up 2.5% of Kopp Investment Advisors's portfolio in Q3 2019, its #13 holding.
  • Kopp Investment Advisors first reported a position in Supernus Pharmaceuticals in Q1 2014 and has held it in 21 quarters since.
  • Kopp Investment Advisors's Supernus Pharmaceuticals position peaked at $15.1M in Q2 2015.
  • 243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.

Based on Kopp Investment Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.